105 related articles for article (PubMed ID: 12965248)
1. Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide.
Venihaki M; Zhao J; Karalis KP
J Neuroimmunol; 2003 Aug; 141(1-2):3-9. PubMed ID: 12965248
[TBL] [Abstract][Full Text] [Related]
2. Modulation of type I IL-1 receptor and IL-1 beta mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse.
Pournajafi Nazarloo H; Takao T; Taguchi T; Ito H; Hashimoto K
J Neuroimmunol; 2003 Jul; 140(1-2):102-8. PubMed ID: 12864977
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis.
Benou C; Wang Y; Imitola J; VanVlerken L; Chandras C; Karalis KP; Khoury SJ
J Immunol; 2005 May; 174(9):5407-13. PubMed ID: 15843539
[TBL] [Abstract][Full Text] [Related]
4. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression.
Labeur MS; Arzt E; Wiegers GJ; Holsboer F; Reul JM
Endocrinology; 1995 Jun; 136(6):2678-88. PubMed ID: 7750492
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone is involved in conditioned stimulus-induced reduction of natural killer cell activity but not in conditioned alterations in cytokine production or proliferation responses.
Perez L; Lysle DT
J Neuroimmunol; 1995 Dec; 63(1):1-8. PubMed ID: 8557820
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function.
Chen CL; Singh N; Yull FE; Strayhorn D; Van Kaer L; Kerr LD
J Immunol; 2000 Nov; 165(10):5418-27. PubMed ID: 11067893
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice.
Agelaki S; Tsatsanis C; Gravanis A; Margioris AN
Infect Immun; 2002 Nov; 70(11):6068-74. PubMed ID: 12379683
[TBL] [Abstract][Full Text] [Related]
8. Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes.
Zhao J; Karalis KP
Mol Endocrinol; 2002 Nov; 16(11):2561-70. PubMed ID: 12403845
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing hormone modulates endotoxin-induced inflammatory cytokine expression in human trophoblast cells.
Wang W; Nan X; Ji P; Dow KE
Placenta; 2007 Oct; 28(10):1032-8. PubMed ID: 17568667
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin.
Paez Pereda M; Sauer J; Perez Castro C; Finkielman S; Stalla GK; Holsboer F; Arzt E
Endocrinology; 1995 Dec; 136(12):5504-10. PubMed ID: 7588301
[TBL] [Abstract][Full Text] [Related]
11. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
Rim HK; Cho W; Sung SH; Lee KT
J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
[TBL] [Abstract][Full Text] [Related]
12. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone regulates IL-6 expression during inflammation.
Venihaki M; Dikkes P; Carrigan A; Karalis KP
J Clin Invest; 2001 Oct; 108(8):1159-66. PubMed ID: 11602623
[TBL] [Abstract][Full Text] [Related]
14. Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice.
Refojo D; Kovalovsky D; Young JI; Rubinstein M; Holsboer F; Reul JM; Low MJ; Arzt E
J Neuroimmunol; 2002 Oct; 131(1-2):126-34. PubMed ID: 12458044
[TBL] [Abstract][Full Text] [Related]
15. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart.
Coste SC; Heldwein KA; Stevens SL; Tobar-Dupres E; Stenzel-Poore MP
Endocrinology; 2001 Aug; 142(8):3537-45. PubMed ID: 11459800
[TBL] [Abstract][Full Text] [Related]
16. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro.
Jessop DS; Harbuz MS; Snelson CL; Dayan CM; Lightman SL
J Neuroimmunol; 1997 May; 75(1-2):135-40. PubMed ID: 9143246
[TBL] [Abstract][Full Text] [Related]
17. Meprin-alpha metalloproteases enhance lipopolysaccharide-stimulated production of tumour necrosis factor-alpha and interleukin-1beta in peripheral blood mononuclear cells via activation of NF-kappaB.
Gao P; Si LY
Regul Pept; 2010 Feb; 160(1-3):99-105. PubMed ID: 20026360
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation.
Bethin KE; Vogt SK; Muglia LJ
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9317-22. PubMed ID: 10922080
[TBL] [Abstract][Full Text] [Related]
19. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model.
Lim D; Kim MK; Jang YP; Kim J
J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208
[TBL] [Abstract][Full Text] [Related]
20. Formation of proinflammatory cytokines in human term myometrium is stimulated by lipopolysaccharide but not by corticotropin-releasing hormone.
Sehringer B; Schäfer WR; Wetzka B; Deppert WR; Brunner-Spahr R; Benedek E; Zahradnik HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4859-65. PubMed ID: 11134154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
